R&D The post-Covid New Normal: a golden opportunity for the NHS? I recently had the pleasure of attending the PING Conference 2022, which had the tagline of ‘
Digital Accelerator aims to promote digital health innovation in Ita... A digital health startup accelerator is launching in Italy, with more than €6 million backing the new enterprise.
Events Partner Content PING Conference 2022 – The Golden Age for Life Sciences Inno... The Golden Age for Life Sciences Innovation
R&D Innovation across the healthcare system is needed to realise... Janssen’s Catherine Taylor, vice-president, EMEA medical affairs, therapy area strategy, discusses the importance of systemic innovation across the healthcare system to realise the full val
Views & Analysis Innovation and access: Improving Europe’s pharmaceutical reg... EMA “lags behind” other international regulators when it comes to approval timelines, finds EFPIA analysis.
Partner Content Partner Content How to innovate and influence people in times of misinformat... Rewind to late 2019.
News Novo sues Lilly over 'misleading' GLP-1 ad campaigning The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
